Orexigen Therapeutics
La Jolla, CA
2
staff members
Company Profile
Orexigen Therapeutics thinks it has the skinny on how to stay trim. The company is developing drugs, under the names Contrave and Empatic (formerly Excalia), intended for use by obese people who are trying to get a grip on the urge to over-eat. The products are designed to control appetite from the central nervous system and contain some of the same chemicals used in drugs approved for the treatment of smoking, alcoholism, and opiate addiction. The development-stage company is conducting late-stage clinical trials on its top two drug candidates.
51 to 200
TypeCompany - Public (OREX)
Revenue$25 to $50 million (USD) per year
IndustryBiotech & Pharmaceuticals
CompetitorsUnknown
Founded
Company site
Share Profile
Staff Members
CEO
Worked since Wednesday, Nov 12 2025
-
ManagerWorked since - -
President & CEOWorked since -
People Also Viewed
-
New York, NYCompany size: 1 to 50 Employees -
New York, New York, United States.Company size: 43,000 -
New York, NYCompany size: 201 to 500 -
Santa Monica, CACompany size: 1 to 50 -
Houston, Texas, United StatesCompany size: 2,800 -
Lawrence, MACompany size: 51 to 200
Claim business page
Only the CEO can claim this profile. If you are the CEO, first
claim your profile and then claim your business page.
